久久亚洲国产成人影院-久久亚洲国产的中文-久久亚洲国产高清-久久亚洲国产精品-亚洲图片偷拍自拍-亚洲图色视频

USEUROPEAFRICAASIA 中文雙語Fran?ais
Business
Home / Business / Industries

GSK probe shows tightened drug sector supervision

Xinhua | Updated: 2013-07-19 10:29

BEIJING - An ongoing probe into suspected economic violations by multinational drugmaker GlaxoSmithKline (GSK) employees is being seen as part of efforts to tighten supervision in the medical sector.

The Ministry of Public Security announced last week that some employees from GSK China are being investigated for suspected bribery and tax-related violations. Four senior executives from the company are being held by police over their alleged involvement.

The probe has shed light on instances of hidden bribery that have driven up medicine prices. However, the case is not the first of its kind to be uncovered in China.

In December last year, the US Securities and Exchange Commission (SEC) charged Eli Lilly and Company for its involvement in instances of alleged bribery that occurred in several countries, including China.

Four months before the Eli Lilly case, Pfizer's subsidiary in China was also found to have been involved in bribery.

The GSK suspects are believed to have several methods of concealment, such as channelling bribes through travel agencies.

It is believed that the exposure of the bribery represents just the tip of the iceberg.

An anonymous medical salesman from North China's Tianjin municipality said salesmen have had to come up with more creative ways to bribe doctors and convince them to raise the cost of their medicine.

"In most cases, the doctors don't extort money in such explicit terms, but it is certain that they will not order products from those who do not give them a 'good return'," he said.

The unfair market advantage that enterprises have gained by using bribery may make it harder for smaller companies to survive and develop. In addition, the costs of bribery are eventually transferred to patients.

According to suspect Liang Hong, a medication that costs only 30 yuan to produce could end up setting patients back 300 yuan due to bribery.

Bribery can also affect patients' health, as bribes may influence doctors' decisions regarding what medication to prescribe.

A commerce official said Wednesday that the GSK probe is part of efforts to improve China's business climate and create equal competition opportunities for domestic and overseas investors.

The official said China firmly opposes any form of commercial bribery, and all companies, Chinese and foreign alike, will be subject to legal sanctions and assume legal responsibility if they break Chinese law.

Most Viewed in 24 Hours
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 欧美精品亚洲精品日韩 | 精品综合久久久久久98 | 一级黄色毛片免费看 | 美女免费黄网站 | 国产精品_国产精品_国产精品 | 欧美一级特黄aa大片在线观看免费 | 亚洲人在线播放 | 日韩在线视频观看 | 俄罗斯aa毛片极品 | 韩国黄色一级毛片 | 免费播放欧美毛片欧美a | 国产在线精品观看一区 | 俄罗斯黄色毛片 | 亚洲第一视频在线观看 | 国产精品久久久久久久久久日本 | 亚洲三级黄色片 | 波多野结衣在线免费视频 | 国产成人久久综合二区 | 国产成人精品免费视频软件 | 成人免费网站在线观看 | 精品真实国产乱文在线 | 欧美一级淫片免费播放口 | 88av视频在线 | 在线满18网站观看视频 | 免费 视频 1级 | 国产短裙黑色丝袜在线观看下 | 久草网视频在线观看 | 欧美成人极品怡红院tv | 国产日本在线视频 | 97国产在线视频公开免费 | 国产成人a福利在线观看 | 午夜在线视频一区二区三区 | 一级毛片视频免费 | 美女拍拍拍爽爽爽爽爽爽 | 国产高清美女一级毛片久久 | 精品国产一区二区三区国产馆 | 亚洲精品一区二区久久这里 | 综合欧美一区二区三区 | 成人黄色免费观看 | 国产爱啪啪 | 欧美色性 |